While it is clear that convalescent plasma has no benefit in non-severe #COVID19 patients, the evidence is less certain in the case of of severe and critically ill patients. So randomized clinical trials for these subgroups should continue https://t.co/Bobq7OTDGq pic.twitter.com/ihScqP5PKV— World Health Organization (WHO) (@WHO) December 7, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


